Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Revenue

Aprogen Medicines had revenue of 36.79B KRW in the quarter ending September 30, 2024, a decrease of -7.69%. This brings the company's revenue in the last twelve months to 147.85B, down -1.61% year-over-year. In the year 2023, Aprogen Medicines had annual revenue of 150.58B with 92.19% growth.

• Revenue (ttm): 147.85B
• Revenue Growth: -1.61%
• P/S Ratio: 1.29
• Revenue / Employee: 603.48M
• Employees: 245
• Market Cap: 221.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	150.58B	72.23B	92.19%
Dec 31, 2022	78.35B	52.05B	197.95%
Dec 31, 2021	26.30B	-100.85B	-79.32%
Dec 31, 2020	127.14B	48.89B	62.48%
Dec 31, 2019	78.25B	27.20B	53.29%